Alphabet introduces wearable for continuous data collection

Cara Livernois | April 18, 2017 | Health Exec | Precision Medicine

Verily, a subsidiary of Alphabet, recently introduced its newly developed Verily Study Watch. This wearable was made more for the clinical research rather than the consumer and offers continuous monitoring, making collecting data as easy as ever.

According to a Verily blog describing the wearable, this device will be capable of measuring data on “electrocardiogram (ECG), heart rate, electrodermal activity and inertial movements” by targeting “cardiovascular, movement disorders and other areas.”

Verily hopes the wearable will be used in the continuous collection of data in real-time, allowing for improved research.

Read the full story by clicking the link below:

Why Alphabet's New Wearable Is Significant -- And What They Left Out

Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

AI in Healthcare

What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?

Cardiovascular Business

Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology.

Radiology Business

Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Alphabet introduces wearable for continuous data collection

Related Content

Around the web